Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.23.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Convertible preferred stock, beginning balance (in shares) at Dec. 31, 2021   0        
Common stock, beginning balance (in shares) at Dec. 31, 2021     12,693,000      
Beginning balance at Dec. 31, 2021 $ 37,219 $ 0 $ 13 $ 246,090 $ (17) $ (208,867)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (4,620)         (4,620)
Issuance of common stock under:            
Matching contribution to 401(k) plan (in shares)     68,000      
Stock Issued During Period, Value, Employee Benefit Plan 176     176    
Equity incentive plan (in shares)     83,000      
Stock-based compensation expense 499     499    
Foreign currency translation adjustments 212       212  
Convertible preferred stock, ending balance (in shares) at Mar. 31, 2022   0        
Common stock, ending balance (in shares) at Mar. 31, 2022     12,844,000      
Ending balance at Mar. 31, 2022 $ 33,486 $ 0 $ 13 246,765 195 (213,487)
Convertible preferred stock, beginning balance (in shares) at Dec. 31, 2022 0 0        
Common stock, beginning balance (in shares) at Dec. 31, 2022 13,203,000   13,203,000      
Beginning balance at Dec. 31, 2022 $ 25,442 $ 0 $ 13 248,813 563 (223,947)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (4,389)         (4,389)
Issuance of common stock under:            
Matching contribution to 401(k) plan (in shares) 0          
Stock Issued During Period, Value, Employee Benefit Plan $ 0          
Equity incentive plan (in shares)     139,000      
Stock-based compensation expense 424     424    
Foreign currency translation adjustments $ (194)       (194)  
Convertible preferred stock, ending balance (in shares) at Mar. 31, 2023 0 0        
Common stock, ending balance (in shares) at Mar. 31, 2023 13,342,000   13,342,000      
Ending balance at Mar. 31, 2023 $ 21,283 $ 0 $ 13 $ 249,237 $ 369 $ (228,336)